Cargando…
Pre-existing immunity modulates responses to mRNA boosters
mRNA vaccines have shown high efficacy in preventing severe COVID-19, but breakthrough infections, emerging variants and waning antibody levels have warranted the use of boosters. Although mRNA boosters have been widely implemented, the extent to which pre-existing immunity influences the efficacy o...
Autores principales: | Dangi, Tanushree, Sanchez, Sarah, Lew, Min Han, Visvabharathy, Lavanya, Richner, Justin, Koralnik, Igor J., Penaloza-MacMaster, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258286/ https://www.ncbi.nlm.nih.gov/pubmed/35794898 http://dx.doi.org/10.1101/2022.06.27.497248 |
Ejemplares similares
-
Pre-existing immunity modulates responses to mRNA boosters
por: Dangi, Tanushree, et al.
Publicado: (2023) -
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody
por: Dangi, Tanushree, et al.
Publicado: (2022) -
Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
por: Dangi, Tanushree, et al.
Publicado: (2021) -
Limiting the priming dose of a SARS CoV-2 vaccine improves virus-specific immunity
por: Sanchez, Sarah, et al.
Publicado: (2021) -
Adoptive B cell therapy for chronic viral infection
por: Chung, Young Rock, et al.
Publicado: (2022)